Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
Interventions
BIOLOGICAL

Fresh frozen plasma

"Intervention Type: Biological~* Intervention Name: Fresh Frozen Plasma (FFP)~* Detailed Description:~* Dosage:Fresh frozen plasma (FFP) will be administered at a dose of 10-15 mL/kg body weight.~* Administration: The FFP will be transfused intravenously under controlled clinical conditions.~* Purpose: The transfusion aims to correct coagulopathy and normalize activated partial thromboplastin time (aPTT) in non-bleeding thrombocytopenic dengue patients.~* Monitoring: Patients will be closely monitored for any adverse reactions or complications during and after the transfusion process. Coagulation parameters, including aPTT, will be measured at baseline, 24 hours, and 48 hours post-transfusion."

Trial Locations (1)

1205

SheikhHasinaNIBPS, Dhaka

All Listed Sponsors
lead

Sheikh Hasina National Institute of Burn and Plastic Surgery

OTHER